Provider review, September 2026
Villas Health carries a 2025 federal warning letter whose opening line names its own website. Its product pages do the unusual thing of pricing the injection and the nasal form of a peptide separately, but every listing surrounds the live price with a struck-through figure and a neighbouring product's price in the same block of text.
Villas Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.
The letter's opening line says the agency reviewed the website content at this seller's own internet address in August 2025 and observed compounded drug products offered there, including semaglutide and sildenafil.
The recipient is named as Las Villas Health Care LLC doing business as Villas Health, at an address in Coral Gables, Florida.
The letter was matched from that opening line rather than from a name search against the federal table.
Each product page prints a one-time purchase price beside a subscription price, with the subscription figure struck through from a higher one and a percentage off printed under it.
The subscription rate is the figure recorded here, because it is the only one of the pair that carries a stated period.
The outright purchase price is noted alongside it, so nobody later corrects one into the other.
Every product page carries a related-products strip whose figures sit in the same run of text as the product's own.
A first pass at the sermorelin injection took a figure from that strip and it was wrong — the number belonged to a neighbouring product.
Each figure recorded here was re-read on the product's own page, from its purchase and subscribe pair, and the strip's numbers were discarded.
In its own words it describes "compounded GLP-1 (available in injections and dissolvable melts), designed to help reduce appetite and improve your metabolism under strict medical supervision", so the compounded status is stated rather than implied away.
It publishes the site in Spanish as well as English from the same navigation.
It names no dispensing pharmacy, publishes no certificate of analysis, and makes no state-coverage claim on the pages read.
Villas Health received an FDA warning letter issued September 2025. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityThe one-time purchase price, which every listing prints beside the subscription rate. The figures recorded here are the subscription rates, because those are the ones with a stated period.
Each listing shows a higher struck-through figure beside the live subscription rate, with a percentage off. That is the seller's own presentation, not a comparison drawn here.
Its opening line says the agency reviewed this seller's website in August 2025 and observed compounded drug products offered there, including semaglutide and sildenafil.
No. The pages read make no state-coverage claim, and no state list is recorded here.
Villas Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.